Categories Earnings, Health Care
Earnings Summary: Here’s how CooperCompanies (COO) performed in Q3 2023
Medical device maker CooperCompanies (NYSE: COO) announced financial results for the third quarter of 2023, reporting an increase in revenues.
- Third-quarter revenue increased 10% year-over-year to $930.2 million; CooperVision and CooperSurgical revenues rose 11% and 8% respectively
- Net income declined to $85.3 million or $1.71 per share in the July quarter from $98.4 million or $1.98 per share a year earlier
- Adjusted earnings per share rose 5% annually to $3.35 during the three-month period
- Gross margin was 66%, up from 65% in last year’s third quarter
- Operating margin decreased to 16% in Q3 from 17% in the comparable period of 2022; adjusted operating margin was 24%
- Interest expense came in at $26.8 million, up from $17.1 million reported a year earlier
- Operating cash flow totaled $142.5 million; adjusted for capital expenditures of $90.9 million, free cash flow was $51.6 million
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
